ANGANY CEO Dr. Louis-Philippe Vézina is pleased to announce the collaboration of Pr. Favrot of the University of Zurich. Pr. Favrot is providing ANGANY with sophisticated insights regarding CAD, an allergy-related condition affecting a substantial proportion of dogs and for which current therapeutics provide only symptomatic relief of limited duration.
